XRCC5 also acts as a binding factor by cooperating with P300 to bind to the COX-2 gene promoter, thus increasing COX-2 expression and subsequently promoting colon cancer growth (Zhang Z. et al., 2017). The gene discussed is XRCC5; the disease is malignant colon neoplasm.